Nanoliposomal irinotecan with fluorouracil and folinic acid, FOLFIRINOX, and S-1 as second-line treatment for unresectable pancreatic cancer after gemcitabine/nab-paclitaxel
Article in Scientific Reports (July 2024)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
Article in Scientific Reports (July 2024)
Article in Biomedicines (April 2024)
Preprint in Research Square (July 2023)